Schizophrenia Research Forum - A Catalyst for Creative Thinking
Home Profile Membership/Get Newsletter Log In Contact Us
 For Patients & Families
What's New
Recent Updates
SRF Papers
Current Papers
Search All Papers
Search Comments
News
Research News
Conference News
Plain English
Forums
Current Hypotheses
Idea Lab
Online Discussions
Virtual Conferences
Interviews
Resources
What We Know
SchizophreniaGene
Animal Models
Drugs in Trials
Research Tools
Grants
Jobs
Conferences
Journals
Community Calendar
General Information
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
History
SRF Team
Advisory Board
Support Us
How to Cite
Fan (E)Mail
The Schizophrenia Research Forum web site is sponsored by the Brain and Behavior Research Foundation and was created with funding from the U.S. National Institute of Mental Health.
Annotation

Budel S, Padukkavidana T, Liu BP, Feng Z, Hu F, Johnson S, Lauren J, Park JH, McGee AW, Liao J, Stillman A, Kim JE, Yang BZ, Sodi S, Gelernter J, Zhao H, Hisama F, Arnsten AF, Strittmatter SM. Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J Neurosci . 2008 Dec 3 ; 28(49):13161-72. PubMed Abstract

Comments on Paper and Primary News
Primary News: Do Faulty Nogo Receptors Allow Axons to Run Amuck in Schizophrenia?

Comment by:  Takeshi SakuraiJoseph D. BuxbaumPatrick R. Hof
Submitted 9 January 2009 Posted 9 January 2009

Several lines of evidence indicate that oligodendrocytes and myelin are disturbed in schizophrenia (Davis et al., 2003; Segal et al., 2007). However, the relationship of these alterations to the pathogenesis of schizophrenia is still unclear. A recent paper by Budel et al. proposes one possible link between oligodendrocyte and myelin pathology and schizophrenia pathogenesis. The gene for Nogo-66 receptor 1 (RTN4R) is located within the 22q11.2 locus where a hemizygous microdeletion (1.5 Mb) occurs at a frequency of one in 5,000. Twenty to 30 percent of individuals with the deletion develop schizophrenia. Several candidate genes for the schizophrenia phenotype within this locus have been characterized for genetic association, and common variants of the Nogo-66 receptor 1 gene have shown association in one study (Liu et al., 2002), but replication studies have not confirmed the findings using different cohorts (  Read more


View all comments by Takeshi Sakurai
View all comments by Joseph D. Buxbaum
View all comments by Patrick R. Hof

Primary News: Do Faulty Nogo Receptors Allow Axons to Run Amuck in Schizophrenia?

Comment by:  Ruby Hsu
Submitted 9 February 2009 Posted 10 February 2009

Individuals with hemizygous microdeletions at the 22q11.2 locus display a range of cognitive and behavioral deficits, and compared to the general population these individuals have a greatly increased risk of developing schizophrenia (Karayiorgou et al., 1995). A number of candidate schizophrenia susceptibility genes have been identified within the 22q11.2 region (Mukai et al., 2004; Paterlini et al., 2005; Paylor et al., 2006; Stark et al., 2008). In our paper (Hsu et al., 2007), we evaluated RTN4R (NgR1), one of the genes in the 22q11.2 region, as a schizophrenia susceptibility gene using a variety of approaches including human association analyses as well as mouse behavioral and anatomical assays. We evaluated common RTN4R variants in a large Afrikaner family sample and found RTN4R polymorphisms which...  Read more


View all comments by Ruby Hsu

Primary News: Do Faulty Nogo Receptors Allow Axons to Run Amuck in Schizophrenia?

Comment by:  Georgia Karoutzou
Submitted 26 February 2009 Posted 26 February 2009

This is a thorough and generally well-written manuscript that provides further evidence to the hypothesis that schizophrenia may be viewed as a disconnectivity syndrome (Frith, 1996; Davis et al., 2003) due to disturbances in myelination.

Even though the authors examined a large sample consisting of 3 different populations (Caucasians, African-Americans and Chinese Han trio sample), they do not provide details regarding the age-ratio of these populations, nor do they report the treatment of these patients. Hence, there is a growing body of evidence of age-related changes in the human brain (Allen et al., 2005).We consider that the authors of this study fail to investigate of how the effects of age are expressed. It can not be ruled out whether there is any effect of the medication in the observed results. Even though medication is not implicated in the observed alterations in gene expression in schizophrenia in several studies (  Read more


View all comments by Georgia Karoutzou
Submit a Comment on this Paper
Make a comment on this paper. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Affiliation  
Country or Territory  
*Login Email Address  
*Confirm Email Address  
*Password  
*Confirm Password  
Remember my Login and Password?  
Get SRF newsletter with recent commentary?  
 
Enter the code as it is shown below:
This code helps prevent automated registrations.

I recommend this paper

Please note: A member needs to be both registered and logged in to submit a comment.

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


 
 
SRF News
SRF Comments
Text Size
Reset Text Size
Email this pageEmail this page

Share/Bookmark
 
Copyright © 2005- 2014 Schizophrenia Research Forum Privacy Policy Disclaimer Disclosure Copyright